GeopoliticsHigh impact
Kymera: Building Toward A Defining 2H26 Moment (NASDAQ:KYMR)
seekingalpha.com·3 hours ago·Global·1 min read
Source: seekingalpha.com
Kymera Therapeutics rated Buy ahead of the 2H26 KT-621 Phase 2b readout.
Click here to read more on KYMR.
When it comes to Kymera Therapeutics ( KYMR ), I would be buy-rated again heading into the 2H26 KT-621 readout.
I see this as the key inflection point for the...
Related news
Geopolitics
NEVIR Dutch IR awards 2026 winners announced
manilatimes.net
Geopolitics
Carter's: Retail Is Improving, But Earnings Still Need To Catch Up (NYSE:CRI)
seekingalpha.com
Geopolitics
The Iridium Deal Changes Everything For Rocket Lab (NASDAQ:RKLB)
seekingalpha.com
Geopolitics
FactSet Research Systems: ASV Acceleration Keeps The Bull Case Going (NYSE:FDS)
seekingalpha.com
Geopolitics
KLA: A Great Business At A Dangerous Price (NASDAQ:KLAC)
seekingalpha.com
Geopolitics
KeyCorp Stock: Focus On Investor Event Disclosures And New Buyback Plan (NYSE:KEY)
seekingalpha.com